Clinical Trials Directory

Trials / Completed

CompletedNCT00783029

Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)

Reproducibility of Dynamic Vessel Analyzer Measurements and Establishment of Standards

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is examine the response of the blood vessels in the eye to a light flicker stimulus using the Dynamic Vessel Analyzer (DVA) on two separate days in healthy individuals. The DVA uses an instrument which is used during routine eye examinations. The hypothesis of the study is that the changes in eye's blood vessel will be similar between the two visits; thus establishing reproducibility of the measurements for future comparisons to individuals with stroke or heart disease. In addition, this study will compare the eye's blood vessel responses to responses of the blood vessels in the arm using Doppler ultrasound.

Detailed description

Retinal blood vessels have been suggested to be an index of the cerebral and coronary microvasculature function. Since the retinal vessels are not under direct sympathetic control, this vascular bed is an ideal location to examine local mechanisms of vascular regulation(i.e. metabolite/endothelial and myogenic). Based on previously published data on animal and human responses, the central purpose for the proposed research is to compare the retinal and brachial vasodilatation responses in healthy subjects using the Dynamic Vessel Analyzer (DVA). Our rationale for this proposal is to better understand retinal blood flow in healthy individuals, gain insight into vascular reactivity in different vascular beds, and lastly to establish standards and reproducibility of DVA Measurements.

Conditions

Timeline

Start date
2008-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2008-10-31
Last updated
2012-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00783029. Inclusion in this directory is not an endorsement.